The Promises and Challenges of Tumor Mutation Burden as an Immunotherapy Biomarker: A Perspective from the International Association for the Study of Lung Cancer Pathology Committee
Lynette M. Sholl, Fred R. Hirsch, David Hwang, Johan Botling, Fernando López‐Ríos, Lukas Bubendorf, Mari Mino–Kenudson, Anja C. Roden, Mary Beth Beasley, Alain Borczuk, Élisabeth Brambilla, Gang Chen, Teh‐Ying Chou, Jin-Haeng Chung, Wendy A. Cooper, Sanja Đačić, Sylvie Lantuéjoul, Deepali Jain, Dongmei Lin, Yuko Minami, André L. Moreira, Andrew G. Nicholson, Masayuki Noguchi, Mauro Papotti, Giuseppe Pelosi, Claudia Poleri, Natasha Rekhtman, Ming‐Sound Tsao, Erik Thunnissen, William D. Travis, Yasushi Yatabe, Akihiko Yoshida, Jillian B. Daigneault, Ahmet Zehir, Solange Peters, Ignacio I. Wistuba, Keith M. Kerr, John Longshore
Topics & Concepts
MedicineBiomarkerImmunotherapyLung cancerOncologyClinical trialCompanion diagnosticSurrogate endpointCancerImmune checkpointDiseaseInternal medicineBioinformaticsBiologyBiochemistryCancer Immunotherapy and BiomarkersCancer Genomics and DiagnosticsLung Cancer Treatments and Mutations